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Splenic Injury During Percutaneous Nephrolithotomy:
A Case Report with Novel Management Technique
Alana C. Desai, M.D.,1 Samay Jain, M.D.,1 Brian M. Benway, M.D.,1
Robert L. Grubb III, M.D.,1 Daniel Picus, M.D.,2 and Robert S. Figenshau, M.D.1

Abstract

We describe a case of a splenic injury caused by a transsplenic percutaneous nephrostomy tract. The case was
completed without incident and the nephrostomy tube was noted to traverse the spleen on routine postoperative
imaging. This rare complication was managed by deposition of Gelfoam pledgets along the transsplenic
nephrostomy tract and placement of a ureteral stent. This novel management technique has not been previously
described in the literature and was successful in the conservative treatment of the uncommon complication of
splenic injury during percutaneous nephrolithotomy.

Introduction

S

plenic injury is a rare but well-recognized complication
of percutaneous nephrolithotomy (PCNL). Treatment
options for this complication have been described in the literature, and range from observation to splenectomy. Evidence regarding iatrogenic splenic injury supports splenic
preservation with either splenorrhaphy or other conservative
measures.1 We describe a case of splenic injury discovered
after PCNL, managed conservatively using a novel technique
of Gelfoam (Pfizer, New York, NY) insertion along the
transsplenic nephrostomy tract. In addition, we performed a
review of the literature to determine risk factors for inadvertent splenic injury as well as approaches to management of
this uncommon complication.
Case Report
A 62-year-old man presented with a 1-year history of left
flank and back pain. His medical history was remarkable for
hypertension and previous myocardial infarction. Computed
tomography (CT) revealed an abdominal aortic aneurysm
and a partial left-sided staghorn calculus with associated
moderate hydronephrosis. The majority of the stone occupied
the renal pelvis, measuring 2.72.1 cm. There were additional
stones in the lower pole, the largest measuring 2.01.0 cm
(Fig. 1). He underwent endoluminal repair of his abdominal
aortic aneurysm before seeking definitive management of the
staghorn calculus. After discussion of treatment options, the
patient elected to undergo PCNL.
Under fluoroscopic guidance, renal access was obtained
through an upper pole calix above the 11th rib. A guidewire

was passed and several attempts were made to negotiate it
down the ureter without success. After these attempts, an
Amplatz wire was coiled in the renal pelvis and the nephrostomy tract was balloon dilated to 30F. The PCNL proceeded without complication. At the end of the procedure, a
7F nephroureteral stent was placed. There was no excessive
bleeding at the conclusion of the case. Nephrostomy tube
placement was confirmed fluoroscopically.
On postoperative day 1, a CT scan was obtained that
showed minimal residual stone. The nephrostomy tube was
noted to traverse the spleen on its course into the collecting system (Fig. 2). There was no evidence of perisplenic
hemorrhage or free fluid in the abdomen. There was no
intraperitoneal-free air to suggest associated injury to the
stomach or bowel.
The patient did not demonstrate signs of bleeding or hemodynamic instability. However, because of the course of the
nephrostomy tube through the spleen, a general surgery
consult was obtained; per their recommendations, the patient
was placed on bed rest and continuous cardiovascular
monitoring. Moderate gross hematuria was noted postoperatively, but the patient’s hematocrit level remained stable
and blood transfusion was not required.
On postoperative day 2, the patient was taken to the
interventional radiology suite for stent internalization and
removal of the nephroureteral stent. Specifically, the nephroureteral stent was exchanged for a 9F vascular sheath,
and an 8F, 24 cm Double-J ureteral stent was placed over an
Amplatz guidewire with the proximal and distal ends coiling
in the renal pelvis and bladder, respectively. A sheet of Gelfoam was cut into pieces and rolled into torpedo-shaped
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FIG. 1. Left partial staghorn calculus (A) and lower pole renal stone (B).
pledgets. Approximately five pledgets were deployed along
the transsplenic nephrostomy tract under fluoroscopic guidance using the inner dilator to push them through the vascular
sheath as the sheath was slowly withdrawn.
The patient remained hemodynamically stable throughout
the remainder of hospitalization and did not require blood
transfusion. He was kept on bed rest until the hematuria resolved, and was discharged on postoperative day 5. The
ureteral stent was removed several weeks postoperatively
without incident. CT scan performed 1 month postoperatively
showed minimal perinephric stranding and urothelial thickening. The patient did not experience any long-term sequelae
or permanent disability as a result of the splenic injury.
Discussion

Indeed, the syndrome of overwhelming postsplenectomy
sepsis is the most serious complication of splenectomy; mortality is associated with splenectomy in 0.026% of adults and
0.052% of children.5 Prophylactic vaccinations while protective may not offer complete immunity because of both vaccination failure and the presence of other bacteria in at least
50% of overwhelming postsplenectomy sepsis cases.6
Splenic conservation has been increasingly utilized in both
adults and children without adverse outcome.7 If operative
management is warranted, however, most are salvageable by
splenorrhaphy or partial resection.2,4 In cases where additional placement of sutures is not optimal, the use of hemostatic agents such as FloSeal (Baxter, Deerfield, IL) has been
described.8 In the current case and those of previously described iatrogenic splenic injuries, hemostatic agents have
been effectively used.

Risks associated with splenic injury
Iatrogenic splenic injuries are a known complication of left
renal surgery. Splenic injury can result in increased operative
time and blood loss, as well as a longer period of convalescence. In addition, splenic injury is associated with an increased risk of infection, a near doubling of the rate of
morbidity, and increased risk of mortality.1 Recent trauma
literature supports splenic preservation because of the lifetime
risk of infectious complications that results from asplenism.2–4

Hemostatic agents
Hemostatic agents are designed to provide hemostasis by
accelerating the blood clotting process. Gelfoam, the hemostatic agent used in this case, is a topical agent consisting of
porcine gelatin formed into a sponge that adheres to sites of
bleeding. Platelets are trapped in the uniform pores and the
clotting cascade is activated. In the case described herein,
Gelfoam pledgets were deployed along the previously de-

FIG. 2. Transsplenic percutaneous nephrostomy tube.
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veloped tract allowing adherence to bleeding sites along the
tract and activation of the clotting cascade. An internal ureteral stent was also left in place to allow healing of the collecting system. The authors chose Gelfoam because of its ease
of deployment through a sheath and proven effectiveness in
hemostasis of liver biopsy tracts.9 The use of this hemostatic
agent has also been described for laceration of the right renal
artery during PCNL.10 FloSeal, composed of a gelatin matrix
in combination with a thrombin component, would have also
been a feasible alternative. The crosslinked gelatin granules in
the matrix expand approximately 20% when it comes into
contact with bodily fluids, thus slowing the flow of blood. The
thrombin component then activates the coagulation cascade.
In this case, it would expand to fill the splenic tract upon
contact followed by activation of the coagulation cascade and
formation of a hemostatic plug. The use of FloSeal has proven
effective in managing small-vessel bleeding associated with
partial nephrectomies.11,12
Other hemostatic agents that have been described in urologic
surgery include fibrin glue and BioGlue (CryoLife, Kennesaw,
GA). The use of fibrin glue, also known as fibrin sealant,
marketed as Tisseel (Baxter) and Hemaseel (Haemacure,
Sarasota, FL) has been described in a series of partial nephrectomies after suture ligation of transected vessels.13 Fibrin glue
has also been successfully used for persistent urine leakage after
renal reconstruction after a gunshot wound and partial nephrectomies.14–16 BioGlue, a liquid adhesive that rapidly polymerizes to form an impermeable seal, has been successfully
employed during partial nephrectomy to address minor splenic
injuries, including capsular tears and even mild laceration.17
Preventing splenic injury
Because of the anatomic relationship of the kidney with the
colon, duodenum, liver, spleen, and pleura, these structures
are at risk for injury during percutaneous renal access.18 Injuries to the liver and spleen, however, are extremely rare.
Liver injuries, in all probability, are not likely a cause of major
morbidity as large drainage tubes are routinely placed during
biliary procedures. In addition, transhepatic PCNL has been
performed intentionally in cases of anatomic aberrancy.19
Splenic injuries, however, require at the very least conservative management, or possibly splenectomy in the event of
significant hemorrhage. Early diagnosis of this complication
is critical to prevent adverse outcomes. The possibility of
splenic injury should be an immediate consideration in the
event of hemodynamic instability after left-sided PCNL, even
in patients without significant hematuria.

For PCNL, a supracostal approach is preferred for the
treatment of upper pole stones, staghorn or complex calculi,
and stones in the proximal ureter20; however, the risk for
visceral injury is greater for tracts placed above the 12th rib.
To assess the safety of a supracostal approach, Hopper and
Yakes evaluated the potential course of a percutaneous access
tract on CT scans obtained during full inspiration and expiration, finding that in the prone position, an 11th to 12th intercostal approach would not be expected to puncture the
liver or spleen during expiration. However, in 14% and 29% of
cases, the tract would be expected to traverse the left and right
lung, respectively. A 10th to 11th intercostal approach during
expiration was associated with a risk of hepatic and splenic
injuries of 14% and 33%, respectively; in addition, the risk of
pleural injury increased to a rate of 86% for the left side and
93% for a right-sided puncture. These findings suggested that
punctures above the 11th rib carry a low risk of solid organ
injury, especially when placement is coupled with expiration.21
For subcostal punctures, the likelihood of splenic injury is
low. The presence of splenomegaly, however, increases the
risk of injury. Ultrasound guidance during needle placement significantly reduces the risk of splenic injury.22 In addition, preoperative cross-sectional imaging with CT or MRI
can further clarify structures adjacent to the kidney when a
supracostal puncture is planned.23
In general, the skin incision for puncture should lie between
the posterior axillary line and the spine to protect adjacent
organs from injury. The puncture site for percutaneous access
in thin patients should be more medial and superior.24 One
must also consider the chance for injury related to needle
placement along the horizontal axis of the body. A more lateral placement of the catheter increases the possibility of injury to the colon, liver, and spleen.25,26 Shah and colleagues27
recommend initial puncture medial to the posterior axillary
line during full inspiration to place the kidney in a subcostal
location, followed by needle insertion during exhalation to
shift the lung and spleen cephalad, thus avoiding the needle
path.
Superior pole access was utilized in this case based largely
on surgeon preference. Contemporary studies demonstrate
improved stone-free rates with a low incidence of pleural injuries with upper pole access.20,28 As such, we feel that the risk
of pleural injury should not impede selection of upper calyceal access if deemed appropriate to maximize stone clearance. Although a multiple-access approach is advocated by
some to avoid a supracostal puncture, its use has been found
to be associated with an increase in bleeding complications.28–31

Table 1. Management of Splenic Injury Detected After Left-Sided Percutaneous Nephrolithotomy
Author

No. of
patients

Schaeffer et al33

3

Shah et al27

2

Carey et al34
Santiago et al24
Goldberg et al10

1
1
1

Injury

Management

Splenic laceration (1)
Observation
Transsplenic catheter (2)
Nephrostomy tube drainage (12–14 days)
Splenic laceration (1)
Ex-lap, fibrin glue
Ruptured splenic hematoma (1)
Splenectomy
Transsplenic catheter
Nephrostomy tube drainage (2 weeks)
Splenic injury=hematoma
Observation
Splenic puncture
Observation

Transfusion
None
None
3 units
4 units
None
1 unit
Yes (quantity
not specified)
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Both upper pole and multiaccess approaches have been found
to be viable with only a small increase in the incidence of
acceptable complications.28
A synchronous bidirectional approach that combines the
use of flexible instruments in a retrograde fashion as well as
through the nephrostomy tract to avoid multiple percutaneous punctures has also been described.32 We prefer to use a
single-access approach, utilizing the upper pole when necessary, with the liberal use of flexible nephroscopy and retrograde intrarenal surgery to achieve optimal stone-free rates. In
general, each case should be individualized; the choice of
access, whether single or multiple, should be weighed against
potential risks without compromising stone clearance.
Conservative management
Although there are relatively few reports of splenic injury
during PCNL in the literature, several case reports have
identified spleen-preserving treatment options (Table 1).
Conservative management, including observation in a monitored unit and serial measurements of hemoglobin or hematocrit levels, has been described.10,33
Santiago et al reported a case of small bowel and splenic
injury detected on CT obtained for abdominal pain, fever, and
postoperative anemia. The patient underwent exploratory
laparotomy for the small bowel injury, and the splenic hematoma was confirmed. The splenic injury was managed
expectantly.24 In cases where injury was discovered before
nephrostomy tube removal, some authors have left the
drainage catheter in place for 12 to 14 days.33,34 Schaeffer
et al33 reported nephrostomy tube removal followed by observation with serial hemodynamic and hemoglobin measurements for 72 hours, whereas Carey and colleagues34
removed the nephrostomy tube after a negative antegrade
nephrostogram. Shah and associates reported two cases of
splenic injury, both requiring exploratory laparotomy; however, only one required splenectomy for ruptured hematoma.
In the second case, there was no active bleeding noted intraoperatively and fibrin glue was placed over the laceration.27 Lastly, splenectomy after PCNL for injuries not
amenable to conservative management has been reported
because of splenic perforation, ruptured hematoma, and excessive bleeding.27,35
In the series reported by Schaeffer et al,33 the greatest degree of blood loss was in the patient whose injury was unrecognized until the time of nephrostomy tube removal; the
other two injuries were incidentally detected before nephrostomy tube removal, allowing prolonged catheter
drainage, and presumably decreased blood loss. The authors
speculated that a postoperative CT scan may be advisable
after upper pole puncture to avoid premature nephrostomy
tube removal in case of inadvertent injury. Others argue that
routine postoperative CT scanning is not cost effective considering the low incidence of visceral injury overall.27
Although extended nephrostomy tube drainage for transsplenic catheter placement has proven successful, it can be
disadvantageous for the patient. Prolonged placement of a
nephrostomy tube may be burdensome for the patient in
terms of increased postoperative pain as well as the inconvenience of caring for an external drainage device. In the case
described herein, this injury was successfully managed
without the need for prolonged catheter drainage or blood

DESAI ET AL.
transfusion. This would undoubtedly improve patient quality
of life as well as decrease the risk of problems related to external drains and complications associated with the transfusion of blood products.
Conclusions
Although relatively uncommon, iatrogenic splenic injury is
a recognized complication of PCNL. The lifelong risks associated with asplenism suggest that splenic preservation and
nonoperative management should be strongly considered for
the hemodynamically stable patient. The use of hemostatic
agents for splenic injury is expanding, supporting prior reports of success in managing a wide variety of splenic and
hepatic injuries. Although it is unclear whether a hemostatic
agent was necessary in this case, its use appears prudent when
potential bleeding cannot be controlled by other means and
when hemostasis is not assured. Prospective studies comparing observation, various hemostatic agents, and nephrostomy tube drainage are lacking, likely because of the
exceedingly low incidence of this complication.
Disclosure Statement
No competing financial interests exist.
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